Evidence map›Paper›PMID 42709908›Full record

ArticlePLoS computational biology2026

Not every gene is special: Modelling scale controls the false discovery rate when analysing high-throughput sequencing data.

Scott J Dos Santos, Andreea C Murariu, Justin D Silverman, Gregory B Gloor

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Scott J Dos SantosDepartment of Biochemistry, Western University, London, Ontario, Canada.ORCID 0000-0001-7793-3501
Andreea C MurariuDepartment of Biochemistry, Western University, London, Ontario, Canada.
Justin D SilvermanProgram in Bioinformatics and Genomics, Pennsylvania State University, University Park, Pennsylvania, United States of America.
Gregory B GloorDepartment of Biochemistry, Western University, London, Ontario, Canada.ORCID 0000-0001-5803-3380

Funding

DMS/NIGMS 1: Addressing Measurement Limitations for Sequence Count DataR01GM148972 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI SILVERMAN, JUSTIN D · 2022 to 2024
$600k
Natural Sciences and Engineering Research Council of CanadaNIGMS NIH HHS R01 GM148972NIH HHS 1R01GM148972-01
6 · The paper itself

Abstract

Differential expression/abundance analyses are commonplace in studies employing high-throughput sequencing (HTS); however different tools often fail to return comparable results when applied to the same dataset. Most tools employ normalisations to attempt to correct for technical variation in the count data. Previously, we demonstrated that these normalisations are often inappropriate due to incorrect assumptions regarding the overall scale (i.e., size) of the biological system in question. In this study, we used a combination of binomial thinning and permutation of sample groupings to produce 100 analysis iterations of 11 RNA-seq and other HTS datasets in which ~5% of all features are expected to be significantly different between groups. This enabled calculation of the false discovery rate (FDR) and sensitivity across the iterations. Our simulations showed that scale misspecification results in poor control of the FDR by several commonly used tools and that, counterintuitively, FDRs increased as the modelled difference between groups increased. Implementing a scale model in ALDEx2 or ALDEx3 ameliorated unacceptably high FDRs; however, there was an inherent trade-off between satisfactory FDR control and high sensitivity- no tool offered both. We established that increasing scale uncertainty also increased the minimum difference between groups required for a feature to be reported as differentially expressed. This phenomenon was consistently observed in disparate types of HTS data and was remarkably consistent. Critically, we leveraged a 'real-world', non-permuted analysis of an RNA-seq dataset to demonstrate that the latter effect is not a result of our thinning/permutation approach. Overall, our work highlights the potentially unwitting choice between sensitivity and FDR control that all researchers are making when analysing sequencing data and provides guidance on choosing an appropriate amount of scale uncertainty for the analysis of HTS data.

Indexed as

Gene Expression ProfilingHigh-Throughput Nucleotide SequencingAnimalsComputational BiologyComputer SimulationHumansModels, GeneticModels, StatisticalSequence Analysis, RNA

Identifiers

PMID42709908
PMCPMC13581218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.